Haberkorn U - Search Results

1

Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene.

Sieger S, Jiang S, Kleinschmidt J, Eskerski H, Schönsiegel F, Altmann A, Mier W, Haberkorn U. Sieger S, et al. Among authors: haberkorn u. Cancer Gene Ther. 2004 Jan;11(1):41-51. doi: 10.1038/sj.cgt.7700654. Cancer Gene Ther. 2004. PMID: 14681725

2

Metabolic design of combination therapy: use of enhanced fluorodeoxyglucose uptake caused by chemotherapy.

Haberkorn U, Reinhardt M, Strauss LG, Oberdorfer F, Berger MR, Altmann A, Wallich R, Dimitrakopoulou A, van Kaick G. Haberkorn U, et al. J Nucl Med. 1992 Nov;33(11):1981-7. J Nucl Med. 1992. PMID: 1432159 Free article.

3

Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.

Haberkorn U, Morr I, Oberdorfer F, Bellemann ME, Blatter J, Altmann A, Kahn B, van Kaick G. Haberkorn U, et al. J Nucl Med. 1994 Nov;35(11):1842-50. J Nucl Med. 1994. PMID: 7965167 Free article.

4

Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.

Haberkorn U, Altmann A, Morr I, Knopf KW, Germann C, Haeckel R, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Feb;38(2):287-94. J Nucl Med. 1997. PMID: 9025757 Free article.

5

Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.

Haberkorn U, Altmann A, Morr I, Germann C, Oberdorfer F, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Jul;38(7):1048-54. J Nucl Med. 1997. PMID: 9225789 Free article.

6

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.

Haberkorn U, Ziegler SI, Oberdorfer F, Trojan H, Haag D, Peschke P, Berger MR, Altmann A, van Kaick G. Haberkorn U, et al. Nucl Med Biol. 1994 Aug;21(6):827-34. doi: 10.1016/0969-8051(94)90162-7. Nucl Med Biol. 1994. PMID: 9234332

7

Metabolic and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs.

Haberkorn U, Oberdorfer F, Klenner T, Strauss LG, Stöhr M, Wallich R, Altmann A, Kaick GV. Haberkorn U, et al. Nucl Med Biol. 1994 Aug;21(6):835-45. doi: 10.1016/0969-8051(94)90163-5. Nucl Med Biol. 1994. PMID: 9234333

8

PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.

Haberkorn U, Bellemann ME, Altmann A, Gerlach L, Morr I, Oberdorfer F, Brix G, Doll J, Blatter J, van Kaick G. Haberkorn U, et al. J Nucl Med. 1997 Aug;38(8):1215-21. J Nucl Med. 1997. PMID: 9255154 Free article.

9

Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase.

Haberkorn U, Khazaie K, Morr I, Altmann A, Müller M, van Kaick G. Haberkorn U, et al. Nucl Med Biol. 1998 May;25(4):367-73. doi: 10.1016/s0969-8051(97)00210-2. Nucl Med Biol. 1998. PMID: 9639298

10

Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase.

Haberkorn U, Bellemann ME, Gerlach L, Morr I, Trojan H, Brix G, Altmann A, Doll J, van Kaick G. Haberkorn U, et al. Gene Ther. 1998 Jul;5(7):880-7. doi: 10.1038/sj.gt.3300679. Gene Ther. 1998. PMID: 9813658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters